Print
Newly Released Records Raise An Old Country Question: When Taxpayers Pay For Government Experiment… Should The Hideous Results Be Hidden?
Suppose you hired somebody to test the water coming out of your well. Then suppose the results raised an ugly question about whether the equipment meant to protect your family was doing its job.
You would want the numbers, the explanation, and somebody willing to answer questions. You probably wouldn’t appreciate hearing that the real problem was how many neighbors had seen the report.
That’s the feeling you get reading the Ebola research records released September 28 by Senator Rand Paul. They describe taxpayer-funded animal experiments, disturbing findings, and an argument inside Washington over whether the results should be classified.
The science deserves careful examination. So does the government’s impulse to pull the curtains.
Your Money Was Already In The Building
The research involved the National Institute of Allergy and Infectious Diseases, then led by Anthony Fauci, and the Army’s infectious-disease research institute at Fort Detrick, Maryland. A 2015 study exposed vaccinated monkeys to aerosolized Ebola under a NIAID task order.
According to the released documents, that study compared four vaccines in groups of four monkeys. NIAID helped shape the study and supplied funding.
This wasn’t somebody’s backyard experiment that Washington discovered after the fact. Federal agencies were involved in paying for it, planning it, and conducting it.
The stated purpose was biodefense: finding out whether medical protections would work against a possible biological attack. That’s a serious question, but a serious purpose doesn’t make every decision sensible or every uncomfortable result a government secret.
If anything, dangerous work demands better oversight. The hotter the stove, the more carefully you watch the kitchen.
The Monkeys Died. What Did That Actually Prove?
Fauci’s notes describe vaccinated animals developing troubling lung damage after aerosol exposure, including inflammation, dead tissue, and fibrin deposits.
One entry records 16 deaths among 20 vaccinated animals—the source of the widely repeated 80 percent figure. But the records contain differing animal counts, so readers should not casually attach that number to the separate four-groups-of-four study.
And here’s another distinction worth keeping straight: deaths following vaccination and deliberate Ebola exposure do not, by themselves, prove that the vaccine caused those deaths. The unusual lung findings raised a question about vaccine-associated harm under those experimental conditions.
That is plenty serious without stretching it.
If a new cattle treatment is followed by trouble, a responsible farmer investigates. He doesn’t declare the treatment innocent because the salesman wears a clean shirt, and he doesn’t pretend he has settled the cause before checking the evidence.
Then Came The Argument Over Who Should Know
In his March 7, 2016 notes, Fauci called the Army researchers “idiots” and wrote that the experiment should have been classified and never performed. Two days later, he described the work as important for biodefense while again arguing for classification.
His frustration also centered on the circulation of the findings. Information had reached the FDA and American embassies in West Africa, where Ebola vaccination efforts were being planned.
According to Fauci’s account, embassy officials became alarmed that the United States might be offering a dangerous vaccine. He believed the experiment’s unusual exposure conditions made that inference misleading.
That concern deserved an explanation. It did not automatically settle whether the information should be hidden.
There’s a mighty big difference between saying, “These results need context,” and saying, “These results need a lock.”
The Security Fence Showed Up After The Trouble
Fauci also wrote that the findings could reveal a vulnerability. That is the strongest stated argument for secrecy in the records, and it deserves to be weighed honestly.
But NIAID’s own internal review said classification had not been raised during the discussions it described. Security clearances had not been requested, manufacturers had received data, and some earlier findings had already been published.
Now picture somebody building a fence around the barn after the whole county has attended the auction. You would reasonably ask what, exactly, the new fence was supposed to protect.
Was there a specific national-security danger? An embarrassing scientific problem? A threat to confidence in a vaccination program? Those concerns can overlap, but they are different questions and deserve different answers.
Fauci’s emails describe his surprise when Defense officials identified NIAID as a funder during a White House discussion. Other correspondence raised damage control, while Fauci reported support from National Security Council officials for his classification position.
None of that proves embarrassment was his only motive. It certainly gives taxpayers grounds to demand an explanation beyond “the experts handled it.”
The Part That Complicates The Story
The same document package contains internal resistance to secrecy. By March 22, NIAID officials were discussing public disclosure with caveats; Michael Kurilla said he did not object to sharing the aerosol data publicly.
That matters. These records show a dispute over disclosure, not proof that every official favored permanent concealment or that classification ultimately happened.
The exposure method matters, too. Researchers distinguished the engineered aerosol challenge from natural infection; the internal review reported protection without the same lung pathology when those vaccine candidates were tested through another exposure route.
You cannot test a roof with a pressure washer pointed upward beneath the shingles and automatically announce what happens during ordinary rain. The test might reveal something important, but you still have to explain what you tested.
Washington owed people that explanation. Concerned citizens deserve the whole record, including the parts that complicate a satisfying headline.
“Keep The Rest Off Email” Is No Confidence Builder
Another exchange concerned whether the work might count as dual-use research—research that could serve protective purposes while also presenting opportunities for misuse. Officials discussed pausing further experiments.
Researcher Peter Jahrling warned that treating aerosol challenge studies that way could undermine the broader medical-countermeasure program. He also wrote that he would keep further discussion off email.
That language does not establish criminal conduct. But it is hardly the sentence you want to find when you’re looking for a clear, durable record of decisions about dangerous research.
His March 14 email also mentions a planned “CoV” study. Some retellings insert “COVID-19,” but the email does not say that, and a 2016 coronavirus reference does not establish a connection to the later pandemic.
There is enough here to investigate without planting evidence the documents don’t contain.
Trust Is Earned With The Books Open
For homesteaders, this is a familiar principle. When something important fails, you inspect it, record what happened, and tell the people depending on it.
You don’t fix a cracked well casing by scolding the fellow who spotted the crack. And you don’t restore confidence in public science by making disclosure sound like the emergency.
Congress should establish who authorized the work, how its risks were reviewed, what follow-up resolved the lung findings, and what ultimately happened to the proposed classification. Taxpayers deserve answers they can check.
The people paying for the barn have every right to ask what’s happening inside it.
